← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2010Last known activity
Oct 10, 2023
Timeline
2000s
- Jun 1, 2000
Affimed GmbH— Founded
Drugs by trial phase (12 distinct, 14 trials)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT05883449Lead sponsorPhase 2Oct 10, 2023
- NCT05883449Study directorPhase 2Oct 10, 2023
- NCT05817058Lead sponsorPhase 1Mar 21, 2023
- NCT05817058Study directorPhase 1Mar 21, 2023
- NCT05109442Study directorPhase 1/Phase 2Nov 19, 2021
- NCT05109442Lead sponsorPhase 1/Phase 2Nov 19, 2021
- NCT05099549CollaboratorPhase 1/Phase 2Nov 3, 2021
- NCT04259450Lead sponsorPhase 1/Phase 2Feb 1, 2020
- NCT04259450Study directorPhase 1/Phase 2Feb 1, 2020
- NCT04101331Lead sponsorPhase 2Dec 31, 2019
- NCT04101331Study directorPhase 2Dec 31, 2019
- NCT04128423Study directorPhase 1Oct 9, 2019
- NCT04128423Lead sponsorPhase 1Oct 9, 2019
- NCT03516591Lead sponsorPhase 1Jun 22, 2018
- NCT03516591Study directorPhase 1Jun 22, 2018
Details
- Founded
- Heidelberg, DE Jun 1, 2000
- Last known activity
- Oct 10, 2023